Two weeks have passed since Nara Organics recalled all of its powdered infant formula following a multistate botulism outbreak. Three babies in California, Pennsylvania, and Washington were hospitalized. All three received the FDA-approved antitoxin and survived.
But the risk window is not over.
The FDA has confirmed that symptoms of infant botulism can take as long as several weeks to develop after formula ingestion. The CDC advises that parents of infants who consumed this formula should watch for symptoms for one month after the last feeding.
For any parent who was using Nara Organics formula — and stopped on June 13, when the recall was announced — that 30-day window extends into mid-July. For parents who stopped earlier, the math is different, but the vigilance should be the same.
Why This Matters
Infant botulism is rare — fewer than 200 cases are confirmed in the United States each year — but it carries an outsized severity. Unlike foodborne botulism in adults, which results from ingesting preformed toxin, infant botulism occurs when Clostridium botulinum spores are swallowed and then germinate in a baby's immature intestinal tract, producing toxins from inside the gut.
This process takes time. The onset of symptoms is not immediate. And because the illness begins with signs that overlap with common infant complaints — constipation, reduced feeding, fussiness — it can be mistaken for colic or a digestive issue before the neurological effects become apparent.
Left untreated, infant botulism can progress to full-body muscle paralysis and respiratory failure, requiring weeks of hospitalization on mechanical ventilation.
What We Know So Far
As of June 13, 2026, three infants were confirmed with infant botulism linked to Nara Organics Whole Milk Organic Powdered Infant Formula. The three infants ranged from two to five months of age when their illness began. All three were hospitalized and treated with BabyBIG (Botulism Immune Globulin Intravenous). No deaths were reported.
The recall covers all lots and both can sizes — 400 grams and 700 grams — of Nara Organics Whole Milk Organic Powdered Infant Formula. The product was sold at Target retail stores nationwide, on Target.com, and on Nara.com between July 2025 and June 2026. No lots have tested positive for C. botulinum, but the recall was issued voluntarily due to the strong epidemiological link between the formula and the confirmed cases.
Recognizing the Warning Signs
The earliest and most common first symptom of infant botulism is constipation. This can be followed quickly or gradually by a cluster of additional signs:
Early warning signs:
- Constipation (often the first symptom noticed)
- Poor feeding or difficulty sucking and swallowing
- Weak cry that is softer than normal or sounds altered
- Decreased facial expression or flat affect
Progressing signs:
- Loss of head control (the baby cannot hold up its head)
- Drooping eyelids (ptosis)
- Sluggish or unresponsive pupils
- Low muscle tone — the baby feels floppy or like a "ragdoll"
- Generalized weakness
Signs requiring immediate emergency care:
- Difficulty breathing or changes in breathing pattern
- Respiratory distress or arrest
According to the Washington State Department of Health, immediate medical care is warranted for any infant who consumed Nara Organics formula and shows poor feeding, loss of head control, difficulty swallowing, or decreased facial expression.
What Doctors and Experts Say
The FDA's investigation advisory is unambiguous: "Botulism can be fatal, and you should take action right away."
According to Contemporary Pediatrics, any infant who consumed Nara Organics formula and presents with constipation, poor feeding, low muscle tone, loss of head control, or facial weakness should be evaluated for infant botulism immediately. Crucially, diagnosis is clinical — based on physical examination — and treatment with BabyBIG should begin immediately upon clinical confirmation, without awaiting laboratory results.
Physicians who suspect infant botulism should call the Infant Botulism Treatment and Prevention Program (IBTPP) at 510-231-7600 for 24/7 case consultation. The IBTPP is operated by the California Department of Public Health and is the world's only producer of BabyBIG.
What the Evidence Shows — and What It Does Not
The CDC has confirmed a direct epidemiological link between the sick infants and Nara Organics formula — meaning all three children were consuming the same product before illness onset. No other common exposure has been identified.
The absence of a positive test for C. botulinum in the formula itself does not rule out contamination. Botulinum spores can be distributed unevenly within a lot, making it statistically possible for contamination to be present in a production batch even when tested samples are negative. This is why all lots were recalled precautionarily.
The investigation remains ongoing, and the FDA has not yet identified the specific source of contamination.
Who Faces the Greatest Risk?
Infant botulism is unique to very young babies. The highest-risk age group is infants in the first six months of life, when the gut microbiome is not yet established enough to prevent C. botulinum spores from germinating and producing toxins. Older children and adults have competitive gut bacteria that prevent spore germination and are not at risk for this form of botulism.
Among those most vulnerable:
- Infants between two and six months of age — the window of highest susceptibility
- Premature infants, who may have even less mature gut defenses
- Infants with gastrointestinal conditions that may further compromise the gut microbiome
What You Can Do Now
- If your infant consumed Nara Organics formula, monitor them closely for symptoms through 30 days after the last feeding. Mark that date on your calendar.
- If your infant shows any of the warning signs above — particularly constipation combined with poor feeding, weak cry, drooping eyelids, or loss of head control — seek emergency medical care immediately. Do not wait to see whether symptoms resolve.
- Call ahead before arriving at the emergency room so clinical staff can prepare for possible infant botulism and contact the IBTPP if needed.
- If you still have an opened can of formula, do not throw it away yet. Write "DO NOT USE" on it and store it safely away from other baby items. If symptoms appear, your state health department may want to test it.
- For unopened cans, throw them away or return them. If you purchased from Nara.com, orders placed in May or June 2026 should already be refunded. Contact Nara for March and April orders.
- For Target purchases, follow Target's in-store or online return process.
Cost and Access: What Patients Should Know
BabyBIG is the only FDA-approved treatment for infant botulism, and it must be obtained through the IBTPP. The cost of BabyBIG is covered by the California Department of Public Health for all confirmed infant botulism cases in the United States, regardless of the family's insurance status or state of residence. Families should not delay seeking care due to cost concerns.
What Happens Next
The FDA's investigation into the root cause of the contamination is ongoing. The agency has said it will update its outbreak investigation page as new information becomes available. MedicalDaily will report any new case counts or findings from the investigation.
The Bottom Line
The Nara Organics recall may be two weeks old, but the risk period has not ended. Infant botulism symptoms can appear up to one month after the last feeding. If your baby consumed this formula and you notice signs of poor feeding, a weak cry, drooping eyelids, loss of head control, or floppiness, go to the emergency room immediately. Do not wait for laboratory tests before asking for treatment. Speed of treatment is everything with this disease.
References
- FDA — Outbreak Investigation of Infant Botulism: Powdered Infant Formula (June 2026)
- CDC — Infant Botulism Outbreak Linked to Powdered Infant Formula, June 2026
- CDC Newsroom — Outbreak Update: Infant Botulism Linked to Powdered Infant Formula
- Washington State Department of Health — 2026 Multistate Infant Botulism Outbreak Linked to Nara Organics
- Contemporary Pediatrics — FDA and CDC Investigating Multistate Infant Botulism Outbreak
